基于无尺度网络分析的2型糖尿病代谢综合征方-药-证关系

目的运用方-证、药-证关系理论,探讨2型糖尿病合并代谢综合征(MS)人群的证候特征及药用特点。方法采集来自多中以的临床住院病例265例,运用无尺度网络等数据挖掘方法,从中药的功效、种类、单味药的频数及不同药的配伍关系探讨其中医证候特征及分类。结果2型糖尿病合并MS中药使用以益气养阴药物为基础,药物功效随病程长短呈现由养阴清热,到益气养阴、清热,再到益气活血、温阳、化湿利水的变化趋势。炙黄芪、太子参是最常用核以药物。与其关联的药物是生地黄、五味子、川芎、当归、赤芍、麦冬、知母等。结论气虚、阴虚是2型糖尿病合并MS的基本证候。早期以阴虚、热盛为主要特征;中期以气阴、阴虚为主,同时与热盛、痰湿(浊)、瘀血共存;晚期,气虚血瘀是主要证候。阳虚、痰湿、水饮是其常见兼夹证。活血祛瘀药贯穿于整个病程始终。

Study of Relationship between Formula (herbs) and Syndrome about Type 2 Diabetes Melliftus Affiliated Metablic Syndrome Based on the Free-scale Network

Objective Approaching characteristic of syndrome of type 2 diabetes mellitus affiliated metablic syndrome, usage of herbs based on the theories of relationship between formula (herbs) and syndrome. Methods Gathering 265 cases coming from multicentric clinic cases, feature of syndrome and classify would be approached by means of free-scale networks. Result Herbs of supplementing Qi and nourishing Yin is its foundation, effectiveness of herbs showed tendency in eliminating heat nourishing yin, then supplementing Qi and nourishing yin, eliminating heat, and invigorate vital energy promoting blood flow, warming yang, dissipating hygrosis for diuresis. Honey-fried radix astragal, pseudostellariae are important herbs, rehmannia dried rhizome, fructus schizandrae, chuanxiong, angelicae sinensis paeoniae rubra ophiopogonis tuber, anemarrhenae are correlation with them. Conclusion Deficiency of vital energy, Yin asthenia are fundamental syndrome of type 2 diabetes mellitus affiliated metablic syndrome. Early, Yin asthenia and excessive heat are cardinal. Intermediate stage, deficiency of vital energy Yin asthenia are fundamental. Meanwhile excessive heat, phlegmatic hygrosis and stagnated blood existed together. Advanced stage, deficiency of vital energy and stagnation of blood are main syndrome. Yang asthenia, phlegmatic hygrosis, retention of fluid in the body are affiliated syndrome frequently. Drug for invigorating blood circulation and eliminating stasis penetrated through the courses all the while.